Role of Nivolumab in the Modulation of PD-1 and PD-L1 Expression in Papillary and Clear Cell Renal Carcinoma (RCC)

The expression and cellular mechanisms of programmed cell death-1 protein (PD-1) and its ligands (PD-L1 and PD-L2) in renal cancer cells are not well known. Here, we aimed to investigate the response of renal carcinoma subtypes to the immune checkpoint inhibitor nivolumab and its impact on related s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bialek, Joanna, Yankulov, Stefan, Kawan, Felix, Fornara, Paolo, Theil, Gerit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776360/
https://www.ncbi.nlm.nih.gov/pubmed/36552000
http://dx.doi.org/10.3390/biomedicines10123244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776360/
https://www.ncbi.nlm.nih.gov/pubmed/36552000
http://dx.doi.org/10.3390/biomedicines10123244

Ejemplares similares